These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 37990448)

  • 41. Safe and effective delivery of high-power, short-duration radiofrequency ablation lesions with a flexible-tip ablation catheter.
    Ptaszek LM; Koruth J; Santangeli P; Piccini JP; Ranjan R; Mahapatra S; Pipenhagen C; Fish JM; Moon LB; Ambrosius NM; Boudlali H; Jensen JA
    Heart Rhythm O2; 2023 Jan; 4(1):42-50. PubMed ID: 36713045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
    Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
    Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myocardial injury and inflammation following pulsed-field ablation and very high-power short-duration ablation for atrial fibrillation.
    Popa MA; Bahlke F; Kottmaier M; Foerschner L; Bourier F; Lengauer S; Telishevska M; Krafft H; Englert F; Reents T; Lennerz C; Caluori G; Jaïs P; Hessling G; Deisenhofer I
    J Cardiovasc Electrophysiol; 2024 Feb; 35(2):317-327. PubMed ID: 38105426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
    Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. High-Power Short-Duration Lesion Index-Guided Posterior Wall Isolation beyond Pulmonary Vein Isolation for Persistent Atrial Fibrillation.
    Conti S; Sabatino F; Fortunato F; Ferrara G; Cascino A; Sgarito G
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629269
    [No Abstract]   [Full Text] [Related]  

  • 46. Pulmonary vein isolation using a higher power shorter duration CLOSE protocol with a surround flow ablation catheter.
    Berte B; Hilfiker G; Russi I; Moccetti F; Cuculi F; Toggweiler S; Ruschitzka F; Kobza R
    J Cardiovasc Electrophysiol; 2019 Nov; 30(11):2199-2204. PubMed ID: 31424123
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High-power, short-duration ablation in the coronary sinus: clinical cases and preliminary observations on swine hearts.
    Ma C; Yin X; Xia Y; Sun J; Dai S; Gao L; Xiao X; Sun Y; Zhang R; Dong Y; Wang Z; Yu X
    J Interv Card Electrophysiol; 2022 Mar; 63(2):311-321. PubMed ID: 33856622
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The superiority of high-power short-duration radiofrequency catheter ablation strategy for atrial fibrillation treatment: A systematic review and meta-analysis study.
    Waranugraha Y; Rizal A; Firdaus AJ; Sihotang FA; Akbar AR; Lestari DD; Firdaus M; Nurudinulloh AI
    J Arrhythm; 2021 Aug; 37(4):975-989. PubMed ID: 34386124
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative Efficacy and Safety Profiles of High-power, Short-duration and Low-power, Long-duration Radiofrequency Ablation in Atrial Fibrillation: A Systematic Review and Meta-analysis.
    Kumar S; Khatri M; Kumar S; Partab FNU; Manoj Kumar FNU; Neha FNU; Suman FNU; Rai L; Sangam FNU; Kumari S; Islam H; Islam R; Patel T
    J Innov Card Rhythm Manag; 2023 Jul; 14(7):5514-5527. PubMed ID: 37492695
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Superior vena cava isolation with 50 W high power, short duration ablation strategy.
    Kusa S; Hachiya H; Sato Y; Hara S; Ohya H; Miwa N; Yamao K; Iesaka Y; Sasano T
    J Cardiovasc Electrophysiol; 2021 Jun; 32(6):1602-1609. PubMed ID: 33949738
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Update on high-power short-duration ablation for pulmonary vein isolation.
    Qiu J; Wang Y; Wang DW; Hu M; Chen G
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2499-2508. PubMed ID: 32621311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cryoablation versus hybrid radiofrequency with high- and very-high-power short-duration catheter ablation for the treatment of paroxysmal atrial fibrillation.
    Kariki O; Mililis P; Saplaouras A; Dragasis S; Patsiotis IG; Chatziantoniou A; Alexiou D; Cheilas V; Letsas KP; Efremidis M
    Hellenic J Cardiol; 2024 Mar; ():. PubMed ID: 38554832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
    Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
    J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Feasibility and safety of pulmonary vein isolation by high-power short-duration radiofrequency application: short-term results of the POWER-FAST PILOT study.
    Castrejón-Castrejón S; Martínez Cossiani M; Ortega Molina M; Escobar C; Froilán Torres C; Gonzalo Bada N; Díaz de la Torre M; Suárez Parga JM; López Sendón JL; Merino JL
    J Interv Card Electrophysiol; 2020 Jan; 57(1):57-65. PubMed ID: 31713704
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Efficacy of high-power and short-duration ablation in patients with atrial fibrillation: a prospective randomized controlled trial.
    Shin DG; Ahn J; Han SJ; Lim HE
    Europace; 2020 Oct; 22(10):1495-1501. PubMed ID: 32810203
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of Catheter Ablation Using Pulmonary Vein Isolation With vs Without Posterior Left Atrial Wall Isolation on Atrial Arrhythmia Recurrence in Patients With Persistent Atrial Fibrillation: The CAPLA Randomized Clinical Trial.
    Kistler PM; Chieng D; Sugumar H; Ling LH; Segan L; Azzopardi S; Al-Kaisey A; Parameswaran R; Anderson RD; Hawson J; Prabhu S; Voskoboinik A; Wong G; Morton JB; Pathik B; McLellan AJ; Lee G; Wong M; Finch S; Pathak RK; Raja DC; Sterns L; Ginks M; Reid CM; Sanders P; Kalman JM
    JAMA; 2023 Jan; 329(2):127-135. PubMed ID: 36625809
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High-power short duration vs. conventional radiofrequency ablation of atrial fibrillation: a systematic review and meta-analysis.
    Ravi V; Poudyal A; Abid QU; Larsen T; Krishnan K; Sharma PS; Trohman RG; Huang HD
    Europace; 2021 May; 23(5):710-721. PubMed ID: 33523184
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Empirical superior vena cava isolation in patients undergoing repeat catheter ablation procedure after recurrence of atrial fibrillation.
    Simu G; Deneke T; Ene E; Nentwich K; Berkovitz A; Sonne K; Halbfass P; Arvaniti E; Waechter C; Müller J
    J Interv Card Electrophysiol; 2022 Nov; 65(2):551-558. PubMed ID: 35857220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparison of Effectiveness and Safety between High-Power Short-Duration Ablation and Conventional Ablation for Atrial Fibrillation: A Systematic Review and Meta-Analysis.
    Jin S; Fu L; Jiang J; Ye X; Liu H; Chen Y; Pu S; Wu S; Xue Y
    J Interv Cardiol; 2022; 2022():6013474. PubMed ID: 36072362
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Very High-Power Short-Duration (HPSD) Ablation for Pulmonary Vein Isolation: Short and Long-Term Outcome Data.
    Seidl S; Mülleder T; Kaiblinger J; Sieghartsleitner S; Alibegovic-Zaborsky J; Sigmund E; Derndorfer M; Kollias G; Pürerfellner H; Martinek M
    J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.